Search
for
Sort by
Research 361–390 of 862
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
- Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism
- Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
- Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women
- The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study
- Estrogen hormone therapy stabilizes lateral hairline in transfeminine patients: Implications for facial feminization surgery
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Androgens and Hirsutism in a Large Cohort of Portuguese Women
- The Impact of Vitamin D Receptor Gene Polymorphisms (FokI, ApaI, TaqI) in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome
- The Role of Probiotics and Synbiotics on Hirsutism
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women
- Criticising Modified Ferriman-Gallwey Scroring System in the Evaluation of Hirsutism in 1034 Turkish Women
- Comparison of Modified Ferriman-Gallwey Score and Biochemical Parameters in the Estimation of the Prevalence of Idiopathic Hirsutism Among Women in the Kurdistan Region
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
- Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
- Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Androgen excess: Investigations and management
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- A systematic review of commonly used medical treatments for hirsutism in women
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
- Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
- Management of Hirsutism
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- The effect of spironolactone on genital skin 5α-reductase activity
- Polycystic ovary syndrome (PCOS)
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome